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Monday, March 7, 2011 261aIn lymphocytes Ca2þ signals are essential for diverse cellular functions. After
antigen binds to the T cell receptor a series of reactions are initiated that gen-
erate IP3 and culminate in an increase in cytosolic Ca
2þ. Mechanisms that re-
move Ca2þ also exert an important influence on the net Ca2þ level. The SERCA
pump resequesters Ca2þ into the ER and the PMCA transports Ca2þ to the ex-
tracellular side. Two key features of the PMCA are its stimulation by Ca2þ-cal-
modulin and by PKA-dependent phosphorylation (Bers, 2001) but in most of
the mathematical models this pump is represented with a simple Michaelis-
Menten formulation due to its small contribution to the overall Ca2þ fluxes.
This is not the case in T cells, Bautista et al (2002) showed that this pump is
the primary means of Ca2þ extrusion in T cells and its activity is modulated
by Ca2þ enabling the cell to adapt to higher Ca2þ values during T cell activa-
tion. Additionally once [Ca2þ]i returned to baseline levels the PMCA recovered
slowly with a time constant of ~ 4 min providing a ‘‘memory’’ of previous
[Ca2þ]i. We created a first order kinetics model of the PMCA that mimics its
activation and recovery as function of [Ca2þ]i (Vmax increased from 30 to
60 nM s1, Km decreased from 500 to 400 nM when fully activated) and incor-
porated into a mathematical description of Ca2þ signaling in T cells (Lympho-
LAB). Our results indicate that modulation of the PMCA activity improves the
stability of Ca2þ signaling by adjusting the pump rate to Ca2þ influx even at
high [Ca2þ]i levels (preventing a harmful Ca
2þ overload). Moreover the delay
in modulation permits small Ca2þ fluxes to increase transiently enhancing Ca2þ
signaling dynamics.1427-Pos Board B337
Potassium Channel Regulation of Thromboxane A2 Receptor Function
Shahab M. Danesh, Min Li, Enrico Stefani, Ligia Toro.
G-protein coupled receptors (GPCRs) and the large-conductance, voltage-
and Ca2þ -activated Kþ channel (MaxiK), are commonly expressed at the
plasma membrane of cells. GPCR activation results in activation or inhibition
of MaxiK channel activity depending on the type of GPCR. For example, ac-
tivation of Thromboxane A2 receptor leads to MaxiK channel inhibition. We
now investigate whether MaxiK channel alpha subunit (Slo1) can talk back
and regulate Thromboxane A2 receptor (TP) function. To this end, we ana-
lyzed two downstream processes of activated TP: activation of the mono-
meric G-protein Rho and stimulation of intracellular calcium release.
Expression of Slo1 in HEK293T cells increased Rho mediated transcriptional
activation of a Rho specific variant of the Serum Response Factor promoter
(SRE.L) by TP agonist, U46619 by 53% (P< 0.05). Accordingly, co-
expression of the Clostridium botulinum C3 transferase, a Rho inhibitor,
completely attenuated U46619 induced stimulation of SRE.L transcription.
Expression of the regulator of G-protein signaling domain domain of p115
rhoGEF (p115 rgRGS), a blocker of TP function, also resulted in 85%
(P<0.05) reduction in U46619 induced stimulation of SRE.L transcription.
Additionally, Slo1 expression increased TP mediated intracellular calcium re-
lease by 65% (P<0.05) and all intracellular calcium release was efficiently
blocked by addition of TP antagonist SQ 29,548. An increase in Rho and
Ca2þ pathways may lead to increased contraction in the vasculature where
thromboxane A receptor and MaxiK channels are expressed. Moreover, the
findings demonstrate a new paradigm in ion channel-GPCR signaling. Sup-
ported by NIH.
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Angiotensin II Type 1 receptor Associates with Maxik Channel Alpha Sub-
unit and Inhibits its Activity
Zhu Zhang, Min Li, Enrico Stefani, Ligia Toro.
Angiotensin II (Ang II) has a large impact in cardiovascular physiology
and serves as the most potent pharmacological target in the treatment of
hypertension. Most of the known physiological effects of Ang II are me-
diated by Angiotensin II type 1 receptor (AT1 receptor). AT1 receptor and
another transmembrane protein, the large conductance calcium-activated
potassium (MaxiK, BK) channel, both abundantly expressed in vascular
smooth muscle cells, are believed to play significant roles in regulating
vascular tone. Our present studies show that co-expression of AT1 receptor
with MaxiK channel results in inhibition of channel activity. AT1 receptor
expression produces a 13-mV or 32-mV rightward shift of voltage neces-
sary to half activate the channel (V1/2). AT1 receptor was also found in
co-immunoprecipitates (co-IP) with MaxiK a subunit (MaxiKa, Slo1) in
HEK293T cells expressing both proteins. Consistent with co-IP results,
a substantial co-localization of AT1 receptor and MaxiKa at the plasma
membrane was observed using live labeling and confocal microscopy. Fur-
thermore, the association of AT1 receptor with MaxiKa was dramatically
increased in response to Ang II stimulation. These results strongly suggest
a novel protein-protein interaction-based regulation of MaxiK channels byAT1 receptor, which will advance our understanding of GPCR-ion channel
interaction network on the fine regulation of vascular tone. Supported by
NIH.
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Nucleoside Diphosphate Kinase B Knockout Mice Have Impaired Activa-
tion of the Kþ channel KCa3.1 Resulting in Defective T Cell Activation
Shekhar Srivastava, Lie Di, Olga Zhdanova, Yi Sun, Zhai Li,
Edward Y. Skolnik.
Nucleoside Diphosphate kinases (NDPK) are encoded by the Nme (non-met-
astatic cell) gene family. While they comprise a family of 10 genes, NDPK-A
and B are ubiquitously expressed and account for most of the NDPK- activ-
ity. We previously showed that NDPK-B activates the Kþ channel KCa3.1
via histidine phosphorylation of the carboxyterminus of KCa3.1, which is
required for T cell receptor (TCR) stimulated Ca2þ flux and proliferation
of activated naive human CD4 T cells. We now report the phenotype of
NDPK-B-/- mice. NDPK-B-/- mice are phenotypically normal at birth with
a normal life span. Although T and B cell development is normal in
NDPK-B-/- mice, KCa3.1 channel activity and cytokine production is mark-
edly defective in T helper 1 (Th1) and Th2 cells, while Th17 function is nor-
mal. These findings phenocopy studies in the same cells isolated from
KCa3.1-/- mice and thereby supports genetically that NDPK-B functions up-
stream of KCa3.1. NDPK-A and B have been linked to an astonishing array
of disparate cellular and biochemical functions, few of which have been con-
firmed in vivo in physiological relevant systems. NDPK-B-/- mice will be an
essential tool to definitively address the biological functions of NDPK-B. Our
finding that NDPK-B is required for activation of Th1 and Th2 CD4 T cells,
together with the normal overall phenotype of NDPK-B-/- mice, suggests that
specific pharmacological inhibitors of NDPK-B may provide new opportuni-
ties to treat Th1 and Th2 mediated autoimmune diseases.
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Distinct Regulation of Slo1 Human Gene by Estrogen and Src
Shahab M. Danesh, Pallob Kundu, Enrico Stefani, Ligia Toro.
Estrogen Receptor Alpha (ERa) is a transcription factor for several genes
via genomic or non-genomic (signaling) mechanisms. We previously
showed that activated ERa induces transcription of the murine large-
conductance, voltage- and Ca2þ -activated Kþ channel (mSlo1) gene
through a genomic-dependent mechanism. Here, we analyzed whether
ERa transcribes humanSlo1 (hSlo1) gene. ERa transcription of the hSlo1
gene takes place at a much lower estrogen (E2) concentration
(EC50=0.07 nM) than for mSlo1 (EC50=0.4 nM), suggesting a different
mechanism of hSlo1 activation by ERa. Accordingly, disruption of the
DNA binding domain of ERa or knockdown of Sp1 protein as a potential
genomic mediator of ERa effect did not alter the up-regulation of hSlo1 in
response to E2. These results rule out direct and Sp-factor -and AP-1 fac-
tor- (absent in hSlo1 promoter)-mediated genomic action of ERa towards
hSlo1 transcription. To identify the non-genomic mechanism involved in
ERa transcriptional action, three candidate pathways (Rho, PI3 Kinase
(PI3K), and Src tyrosine kinase) were explored utilizing DNA binding do-
main mutant (DBDM) variant of ERa. Inhibition of Rho function by co-
expression of Clostridium toxin transferase (C3) had no effect on E2 action.
However, inhibition of PI3K activity with 10 mM LY294002 resulted in
a 44% decrease in E2-stimulated hSlo1 expression (P<0.05). Interestingly,
blockade of Src activity with 10 mM PP2 did not inhibit E2 action but
caused a 2 fold increase in the basal level of hSlo1 transcription to levels
attained with E2 activation (P<0.05). Conversely, constitutively active cSrc
(Y527F) completely abolished basal and E2 mediated activation of hSlo1
transcription. These results indicate that PI3K plays a role in E2 mediated
hSlo1 gene expression while Src activity does not mediate E2-induced
hSlo1 transcription but serves as a repressor of hSlo1 gene expression. Sup-
ported by NIH.
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Paxilline, a Closed BK Channel Blocker
Yu Zhou, Christopher J. Lingle.
The tremorogenic fungal metabolite, paxilline, is widely used as a potent and
relatively specific blocker of Ca2þ- and voltage-activated Slo1 (or BK) Kþ
channels. Little is known about the mechanism of paxilline blockade, although
paxilline has been proposed to act in an allosteric manner to influence the
closed-open equilibrium and block by paxilline has been shown to be Ca2þ -de-
pendent, with weakened block at more elevated Ca2þ. Our previous study
shows that block by paxilline is absolutely dependent on the presence of Gly-
cine311 in the BK S6 helix, suggesting that block may occur within the BK
